Nebraska's NCI-designated centre, a longstanding leader in lymphoma classification and transplant and in pancreatic cancer early detection research.
The Fred & Pamela Buffett Cancer Center, whose research and hospital tower opened in Omaha in 2017, is the NCI-designated centre of the University of Nebraska Medical Center and Nebraska Medicine, descended from the Eppley Institute (1961). James Armitage and the Nebraska Lymphoma Study Group shaped lymphoma classification and pioneered autologous transplant for lymphoma, a tradition continued by Julie Vose. The pancreatic cancer programme under Michael Hollingsworth holds an NCI SPORE and coordinates early-detection consortia on mucins and biomarkers. Rural outreach across the Great Plains is a defining feature of its catchment.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-08.
Matched to Fred and Pamela Buffett Cancer Center, including child institutions. 190 works · 5,384 citations · 75% open access · 7% clinical trials · 1% reviews.
Shares NCI-Designated Cancer Centers, Allogeneic stem cell transplantation, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Pancreatic ductal adenocarcinoma.
Shares NCI-Designated Cancer Centers, Allogeneic stem cell transplantation, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Pancreatic ductal adenocarcinoma.
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Pancreatic ductal adenocarcinoma.
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Pancreatic ductal adenocarcinoma.
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/